The integration of individual participant data (IPD) from multiple cohorts will facilitate unified covariate adjustment, enable comprehensive subgroup analyses, and allow for the robust assessment of dose-response relationships between IGF-I levels and cancer risk. The gene discussed is IGF1; the disease is cancer.